Procedures To Apply for Company-Specific Onshoring Agreements To Obtain Tariff Adjustments for Pharmaceuticals and Pharmaceutical Ingredients Under Proclamation 11020
BIS ruleTariff cut or exemptionFederal Register 05/13Open the original
Summary
BIS sets out how pharmaceutical companies can apply for company-specific onshoring agreements under Proclamation 11020. Approved companies pay a reduced Section 232 rate of 20 percent instead of 100 percent on patented drugs, and zero until January 20, 2029, if they also sign MFN pricing deals with HHS. Applications are requested by June 12, 2026.
By industry
- Healthcare & Drug Pricing1 trading day+0.0%p15 stocks5 trading days+1.9%p15 stocks20 trading days+6.1%p15 stocks
“Companies that enter into such agreements are eligible for a reduced Section 232 duty rate for imports of their pharmaceutical products”
- Tariffs & Reshoring1 trading day+1.1%p15 stocks5 trading days−3.2%p15 stocks20 trading days+9.9%p15 stocks
“Company-Specific Onshoring Agreements To Obtain Tariff Adjustments”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 26/05/12 | 0.0% | 0.0% |
| 26/05/13 | +0.8% | +0.8% |
| 26/05/14 | +1.0% | +1.4% |
| 26/05/15 | −0.2% | +0.0% |
| 26/05/18 | +0.4% | +0.3% |
| 26/05/19 | +1.4% | −0.5% |
| 26/05/20 | +0.7% | +0.1% |
| 26/05/21 | +1.4% | +0.8% |
| 26/05/22 | +2.8% | +1.0% |
| 26/05/26 | +1.4% | +1.8% |
| 26/05/27 | +1.9% | +1.8% |
| 26/05/28 | +2.4% | +2.4% |
| 26/05/29 | +1.4% | +2.5% |
| 26/06/01 | −0.1% | +2.6% |
| 26/06/02 | −0.7% | +3.0% |
| 26/06/03 | −0.2% | +1.8% |
| 26/06/04 | +2.9% | +2.5% |
| 26/06/05 | +4.3% | −0.3% |
| 26/06/08 | +3.8% | +0.2% |
| 26/06/09 | +4.9% | −0.2% |
| 26/06/10 | +4.3% | −1.8% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
- Hyundai Steel 004020
- POSCO Holdings 005490
- SeAH Steel Holdings 003030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Dermot Mark Durcan
BuyCencora
BuyCencora
COR
$1.1M
4,000 sh
$1.1M
Filed 05/28
Traded 05/28
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$13.6M
13,620 sh
$13.6M
Filed 05/07
Traded 05/06
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$187.3M
1,983,387 sh
$187.3M
Filed 05/21
Traded 05/19
- Keith Harvey
SellKaiser Aluminum
SellKaiser Aluminum
KALU
$8.2M
47,001 sh
$8.2M
Filed 04/29
Traded 04/27
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$74.6M
797,628 sh
$74.6M
Filed 05/21
Traded 05/20
- Leon J. Topalian
SellNucor
SellNucor
NUE
$5M
21,954 sh
$5M
Filed 05/19
Traded 05/15
- Leon J. Topalian
SellNucor
SellNucor
NUE
$3.7M
16,239 sh
$3.7M
Filed 05/19
Traded 05/15
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$34.6M
370,462 sh
$34.6M
Filed 05/21
Traded 05/21
- John Boozman
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1K–$15K
Joint
$1K–$15K
Reported 07/13
Traded 06/04
- Celso L. Goncalves Jr.
SellCleveland-Cliffs
SellCleveland-Cliffs
CLF
$2.9M
214,308 sh
$2.9M
Filed 06/05
Traded 06/05
- Patrick Hugh Conway
SellUnitedhealth Group
SellUnitedhealth Group
UNH
$284K
800 sh
$284K
Filed 04/27
Traded 04/23
- Kathryn E. Wengel
SellJohnson & Johnson
SellJohnson & Johnson
JNJ
$2.4M
10,000 sh
$2.4M
Filed 06/12
Traded 06/11
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$2.2M
2,208 sh
$2.2M
Filed 05/07
Traded 05/06
- Leon J. Topalian
SellNucor
SellNucor
NUE
$2.1M
9,366 sh
$2.1M
Filed 05/19
Traded 05/15
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$14.5M
152,691 sh
$14.5M
Filed 05/21
Traded 05/20
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$1.4M
10,900 sh
$1.4M
Filed 06/02
Traded 06/01
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$11.9M
41,099 sh
$11.9M
Filed 05/14
Traded 05/12
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$11.4M
38,487 sh
$11.4M
Filed 05/14
Traded 05/12
- Tommy Tuberville
Full salePfizer
Full salePfizer
PFE
$15K–$50K
Joint
$15K–$50K
Reported 07/16
Traded 06/08
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$10.3M
34,641 sh
$10.3M
Filed 05/14
Traded 05/12